Delivery Order SPE2DB22D3016-SPE2DB25FAVE1

Award Date 4/30/25
Potential Completion Date 5/1/25
Potential Value $2.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Aimovig 140 mg/ml autoinjectors, a medication used for the prevention of migraine. The contract has a ceiling value of $3,052.74 and a period of performance through April 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Aimovig 140 mg/ml autoinjector medication. The contract has a firm fixed price and a ceiling value of $13,312.46. It is a non-set-aside award, indicating open competition. The contract has an ultimate completion date of April 18, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a medication used to treat migraines. The contract has a ceiling value of $3,457.44 and is a firm fixed-price, non-set-aside contract with an ultimate completion date of April 29, 2025. AmerisourceBergen Drug Corporation holds a significant Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML, a medication used for the treatment of migraines. The contract has a ceiling value of $4,132.83 and a period of performance ending on April 23, 2025. It is a firm-fixed-price contract, and there is no set-aside designation, indicating open competition. AmerisourceBergen...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,526.34, is for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML, a medication used for the treatment of migraines. The contract has an ultimate completion date of January 21, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,791.70, is for the supply of Aimovig 140 MG/ML autoinjectors. The contract has a firm fixed price pricing type and a period of performance running through May 2, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $3,341.94 firm-fixed-price contract is for the delivery of Aimovig 140 mg/mL autoinjectors, a medication used for migraine treatment. The order has an ultimate completion date of December 8, 2023. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which...
This federal contract award, valued at $8,129.55, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Aimovig 140 mg/ml autoinjectors, a medication used to treat migraine. The contract is a firm fixed-price delivery order with an ultimate completion date of April 10, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,623.42 firm fixed-price contract is for the supply of Aimovig 140 mg/ml autoinjectors, a medication used to prevent migraine headaches. The contract has an ultimate completion date of May 26, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of the medication Aimovig 140 mg/ml autoinjector and has a ceiling value of $39,861.17. It is a firm fixed-price contract with an ultimate completion date of April 28, 2025. The contract is not set-aside and was awarded on April 25, 2025. AmerisourceBergen Drug Corp holds a...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB25FAVE1
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Aimovig 140 mg/ml autoinjectors, a medication used to treat migraines. The contract has a ceiling value of $2,681.05 and a completion date of May 1, 2025. It is a firm-fixed-price contract, which means the price will not change regardless of the contractor's costs. The contract is not designated as a set-aside, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.

Generated 7/30/25, 10:02 AM